Literature DB >> 35511757

Approach to the Patient: Hyponatremia and the Syndrome of Inappropriate Antidiuresis (SIAD).

Julie Martin-Grace1, Maria Tomkins1, Michael W O'Reilly1, Chris J Thompson1, Mark Sherlock1.   

Abstract

Hyponatremia is the most common electrolyte disturbance seen in clinical practice, affecting up to 30% of acute hospital admissions, and is associated with significant adverse clinical outcomes. Acute or severe symptomatic hyponatremia carries a high risk of neurological morbidity and mortality. In contrast, chronic hyponatremia is associated with significant morbidity including increased risk of falls, osteoporosis, fractures, gait instability, and cognitive decline; prolonged hospital admissions; and etiology-specific increase in mortality. In this Approach to the Patient, we review and compare the current recommendations, guidelines, and literature for diagnosis and treatment options for both acute and chronic hyponatremia, illustrated by 2 case studies. Particular focus is concentrated on the diagnosis and management of the syndrome of inappropriate antidiuresis. An understanding of the pathophysiology of hyponatremia, along with a synthesis of the duration of hyponatremia, biochemical severity, symptomatology, and blood volume status, forms the structure to guide the appropriate and timely management of hyponatremia. We present 2 illustrative cases that represent common presentations with hyponatremia and discuss the approach to management of these and other causes of hyponatremia.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  SIAD; fluid restriction; hypertonic saline; hyponatremia; tolvaptan

Mesh:

Year:  2022        PMID: 35511757      PMCID: PMC9282351          DOI: 10.1210/clinem/dgac245

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   6.134


  154 in total

Review 1.  The syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  F C Bartter; W B Schwartz
Journal:  Am J Med       Date:  1967-05       Impact factor: 4.965

Review 2.  Clinical review: the use of vaptans in clinical endocrinology.

Authors:  Alessandro Peri
Journal:  J Clin Endocrinol Metab       Date:  2013-02-11       Impact factor: 5.958

3.  Hyponatremia in a hospital population.

Authors:  A Natkunam; C C Shek; R Swaminathan
Journal:  J Med       Date:  1991

4.  Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis.

Authors:  B K Kleinschmidt-DeMasters; M D Norenberg
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

5.  Active management of hyponatraemia and mortality in older hospitalised patients compared with younger patients: results of a prospective cohort study.

Authors:  Owen Thorpe; Martin Cuesta; Ciaran Fitzgerald; Owen Feely; William P Tormey; Mark Sherlock; David J Williams; Chris J Thompson; Aoife Garrahy
Journal:  Age Ageing       Date:  2021-06-28       Impact factor: 10.668

6.  Current treatment practice and outcomes. Report of the hyponatremia registry.

Authors:  Arthur Greenberg; Joseph G Verbalis; Alpesh N Amin; Volker R Burst; Joseph A Chiodo; Jun R Chiong; Joseph F Dasta; Keith E Friend; Paul J Hauptman; Alessandro Peri; Samuel H Sigal
Journal:  Kidney Int       Date:  2015-02-11       Impact factor: 10.612

7.  Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis.

Authors:  Jorge Gabriel Ruiz-Sánchez; Ivan J Núñez-Gil; Martin Cuesta; Miguel A Rubio; Charbel Maroun-Eid; Ramón Arroyo-Espliguero; Rodolfo Romero; Victor Manuel Becerra-Muñoz; Aitor Uribarri; Gisela Feltes; Daniela Trabattoni; María Molina; Marcos García Aguado; Martino Pepe; Enrico Cerrato; Emilio Alfonso; Alex Fernando Castro Mejía; Sergio Raposeiras Roubin; Luis Buzón; Elvira Bondia; Francisco Marin; Javier López Pais; Mohammad Abumayyaleh; Fabrizio D'Ascenzo; Elisa Rondano; Jia Huang; Cristina Fernandez-Perez; Carlos Macaya; Paz de Miguel Novoa; Alfonso L Calle-Pascual; Vicente Estrada Perez; Isabelle Runkle
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-30       Impact factor: 5.555

8.  Hyponatremia is associated with poor outcome in COVID-19.

Authors:  Hugo De Carvalho; Thibault Letellier; Matilde Karakachoff; Geoffrey Desvaux; Hélène Caillon; Emmanuelle Papuchon; Maxime Bentoumi-Loaec; Nesrine Benaouicha; Emmanuel Canet; Guillaume Chapelet; Paul Le Turnier; Emmanuel Montassier; Armine Rouhani; Nicolas Goffinet; Lucile Figueres
Journal:  J Nephrol       Date:  2021-04-07       Impact factor: 3.902

9.  Association between borderline dysnatremia and mortality insight into a new data mining approach.

Authors:  Yannick Girardeau; Anne-Sophie Jannot; Gilles Chatellier; Olivier Saint-Jean
Journal:  BMC Med Inform Decis Mak       Date:  2017-11-22       Impact factor: 2.796

10.  Estimated Daily Urine Volume and Solute Excretion from Spot Urine Samples to Guide the Therapy of Hyponatremia in SIADH.

Authors:  Guy Decaux; Wim Musch
Journal:  J Clin Med       Date:  2019-09-20       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.